-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tertomotide in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tertomotide in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tertomotide in Alzheimer's Disease Drug Details: Tertomotide hydrochloride (Riavax) is a peptide...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tertomotide in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tertomotide in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tertomotide in Breast Cancer Drug Details: Tertomotide hydrochloride (Riavax) is a peptide...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Catequentinib Hydrochloride in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Catequentinib Hydrochloride in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Catequentinib Hydrochloride in Endometrial Cancer Drug Details: Catequentinib hydrochloride (AL-3818)...
-
Product Insights
Non Alcoholic Fatty Liver Disease (NAFLD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Non Alcoholic Fatty Liver Disease (NAFLD) - Drugs In Development, 2023’, provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Non Alcoholic Fatty Liver Disease (NAFLD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Progressive Supranuclear Palsy – Drugs In Development, 2023
Global Markets Direct’s, ‘Progressive Supranuclear Palsy - Drugs In Development, 2023’, provides an overview of the Progressive Supranuclear Palsy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Progressive Supranuclear Palsy , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally,...
-
Product Insights
Benign Prostatic Hyperplasia – Drugs In Development, 2023
Global Markets Direct’s, ‘Benign Prostatic Hyperplasia - Drugs In Development, 2023’, provides an overview of the Benign Prostatic Hyperplasia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Benign Prostatic Hyperplasia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tertomotide in Progressive Supranuclear Palsy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tertomotide in Progressive Supranuclear Palsy Drug Details: Tertomotide hydrochloride (Riavax) is a peptide vaccine. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RT-401 in Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RT-401 in Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RT-401 in Lung CancerDrug Details: RT-401 is under development for the treatment of...